Molecular Partners Announces all Board Proposals Approved, Clare Fisher Elected as New Board Member at Annual General Meeting [Yahoo! Finance]
Molecular Partners AG - American Depositary Shares (MOLN)
Company Research
Source: Yahoo! Finance
LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced that Clare Fisher was elected by shareholders to its Board of Directors at the Annual General Meeting (AGM). The appointment, and all other motions proposed by the Board of Directors at the AGM, were approved by the shareholders of the Company by a wide majority. “Clare Fisher is an outstanding addition to our Board and we warmly welcome her. Clare's extensive business and corporate development experience in the pharmaceutical and biotech industry will be valuable for our partnerships and expanding pipeline of new drug candidates,” said Bill Burns, Chairman of the Board of Directors of Molecular Partners. Clare Fisher is currently the SVP for Global Business Development and M&A at BeOne Medicines, a global oncology company committed to discovering and devel
Show less
Read more
Impact Snapshot
Event Time:
MOLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MOLN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MOLN alerts
High impacting Molecular Partners AG - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
MOLN
News
- Molecular Partners Announces all Board Proposals Approved, Clare Fisher Elected as New Board Member at Annual General MeetingGlobeNewswire
- Molecular Partners (MOLN) had its "sell (d-)" rating reaffirmed by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors [Yahoo! Finance]Yahoo! Finance
- Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins’ Amenability to Multiple IsotopesGlobeNewswire
- Molecular Partners to Hold Three Poster Presentations at AACR 2026 [Yahoo! Finance]Yahoo! Finance
MOLN
Earnings
- 3/12/26 - Miss
MOLN
Sec Filings
- 3/13/26 - Form 6-K
- 3/12/26 - Form 6-K
- 3/12/26 - Form 20-F
- MOLN's page on the SEC website